Response to low dose temozolomide in radiation induced gliomatosis cerebri

Med Pediatr Oncol. 2003 Dec;41(6):562-4. doi: 10.1002/mpo.10221.

Authors

D Hargrave¹, E Bouffet, J Gammon, L Becker, J Rutka, S Baruchel

Affiliation

¹ New Agent and Innovative Therapy Program, Hospital for Sick Children, Toronto, Canada. darren.hargrave@sickkids.ca

PMID: 14595716
DOI: 10.1002/mpo.10221

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Antineoplastic Agents, Alkylating / therapeutic use*
Brain Neoplasms / drug therapy*
Brain Neoplasms / pathology
Dacarbazine / analogs & derivatives*
Dacarbazine / therapeutic use*
Female
Humans
Leukemia, B-Cell / drug therapy
Leukemia, B-Cell / radiotherapy
Magnetic Resonance Imaging
Neoplasms, Neuroepithelial / drug therapy*
Neoplasms, Neuroepithelial / pathology
Neoplasms, Radiation-Induced / drug therapy*
Neoplasms, Radiation-Induced / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy
Temozolomide
Treatment Outcome

Substances

Antineoplastic Agents, Alkylating
Dacarbazine
Temozolomide